Related Experiment Video
Updated: May 19, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Achromobacter species endocarditis: A case report and literature review
Catherine Derber1, Kara Elam, Betty A Forbes
1Department of Medicine, Division of Infectious Diseases, Virginia Commonwealth University Medical Center;
Abstract:
Endocarditis due to Achromobacter species is a rare, yet serious, endovascular infection. Achromobacter species infective endocarditis is associated with underlying immunodeficiencies or prosthetic heart valves and devices. A case of prosthetic pulmonary valve endocarditis secondary to Achromobacter xylosoxidans subspecies denitrificans is described in the present report. This life-threatening infection was successfully treated with combined valve replacement and prolonged antibiotic therapy. A Medline/PubMed literature review of Achromobacter endocarditis was also performed. Achromobacter species are an uncommon, yet important, cause of nosocomial endocarditis. Given the significant associated morbidity and mortality, along with a high degree of intrinsic antibiotic resistance, Achromobacter species infective endocarditis remains a clinical treatment challenge.
Insights
Achromobacter species cause rare but serious endocarditis, often in patients with heart valves or immunodeficiencies. Successful treatment involves surgery and antibiotics, though resistance remains a challenge.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Endocarditis is a severe infection of the heart's inner lining.
- Achromobacter species are increasingly recognized as opportunistic pathogens.
- Risk factors include prosthetic heart valves and compromised immune systems.
Observation:
- A case of prosthetic pulmonary valve endocarditis caused by Achromobacter xylosoxidans subspecies denitrificans is presented.
- This rare infection highlights the potential for Achromobacter species to cause severe endovascular disease.
- A literature review on Achromobacter endocarditis was conducted.
Findings:
- Achromobacter species are an uncommon but significant cause of hospital-acquired endocarditis.
- The case demonstrates successful management through combined surgical intervention (valve replacement) and extended antibiotic treatment.
- Intrinsic antibiotic resistance in Achromobacter species poses a therapeutic challenge.
Implications:
- Early recognition and appropriate management are crucial for improving outcomes in Achromobacter endocarditis.
- This case underscores the importance of considering unusual pathogens in complex cardiac infections.
- Further research into effective antibiotic strategies for Achromobacter infections is warranted.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
